PHARMACIST PRESCRIBING MODEL GETS FURTHER SUPPORT FROM STATE HEALTH Training rolls out to support full scope of practice for pharmacists ready and interested
With
Kate Gunthorpe,
Pharmacist Implementation & Change Specialist
TerryWhite Chemmart &
Adjunct Lecturer & Examiner
James Cook University &
Pharmacist Prescriber,
Brisbane Metro, Rural and Regional
Esmond Biesiek-Wright, Pharmacist & Network Partner,
TerryWhite Chemmart Compounding Ainslie (ACT)
EARNED MEDIA SEGMENT
Filmed in Brisbane & Canberra | September 2025
Legislative and regulatory changes following the success of the pharmacist prescriber model in Queensland are continuing with NSW Premier Chris Minns in early September 2025 announcing additional training centres from 2026, making permanent pharmacist treatment for certain dermatological conditions and outlining plans to assess pharmacists prescribing antiviral medications for influenza.
A full scope pharmacist prescriber model allows pharmacists to independently prescribe medicines within their professional competence, without requiring prior doctor authorisation. It extends pharmacists’ role beyond dispensing to include assessment, diagnosis of minor and chronic conditions, initiation and modification of therapy, and ongoing patient monitoring. This model integrates pharmacists into primary care teams, aiming to improve timely access to treatment, reduce pressure on general practitioners, and enhance continuity of care. Pharmacists use their clinical knowledge, patient records, and collaborative pathways to ensure safe prescribing. The model emphasises training, regulation, and accountability to maintain high standards of patient safety.
Pharmacist prescribing plays a crucial role in alleviating the pressure on emergency services and general practitioners, allowing pharmacists to enhance their skills and job satisfaction while welcoming more pharmacy students into the workforce for fulfilling careers. Kate Gunthorpe, an Implementation and Change Specialist at TerryWhite Chemmart and a pharmacist prescriber serving Brisbane and its surrounding areas, points to a pilot program established in Far North Queensland that were the origins of the model. This initiative permitted pharmacists to autonomously prescribe for 22 common acute conditions without the need for GP intervention.
At present, Queensland stands at the forefront of full-scope pharmacist prescribing, with Northern Territory and Western Australia beginning educational programs to support this practice. Other regions, including Victoria, Tasmania, and South Australia, are developing similar programs, while Australian Capital Territory is expected to follow suit shortly in early 2026.
Esmond Biesiek-Wright, a partner pharmacist at TerryWhite Chemmart Compounding Ainslie, spoke to Australian Health Journal. He emphasises the importance of fostering collaboration with GPs, noting a shift from transactional interactions to more collegial relationships, to support the patient needs.
Since beginning her training for pharmacist prescribing through James Cook University, Kate is dedicated to ensuring her community benefits from these advancements and is optimistic about the future of pharmacist prescribing across Australia, promoting better health outcomes for all.
Source: Written by AUDIENCED
-
Changes in MBS bulk billing incentives address GP capacity in women’s health
Dr. Sneha Wadhwani, a General Practitioner in Bondi, and Conjoint Lecturer at UNSW School of Medicine, is actively involved in enhancing women’s health services across Australia. As the Co-founder and Clinical Director of Evoca Women’s Health, she highlights the significant improvements in funding for women’s health, particularly with the new MBS bulk billing incentives, in new codes, that commenced on November 1, 2025.
-
Nuclear medicine funding a win for men with prostate cancer
Australian men with higher risk prostate cancer now have access to a nuclear medicine scan to help detect and treat metastatic disease, after it was listed on the Medical Benefits Schedule (MBS) from 1st July 2022.
In 2021 over 18,000 Australian men were diagnosed with prostate cancer, resulting in over 3,000 lives being lost – and making prostate cancer Australia’s second most common cause of cancer death in men.
Australian Health Journal spoke with AANMS President Associate Professor Sze Ting Lee and Dr Geoff Schembri on the MBS listing and the efforts to get it listed.
-
Allied Health Leader shares career insights
Mirella Vagnarelli is a distinguished healthcare leader with proven expertise across South Australia and the United Kingdom, where she has successfully led large, multidisciplinary teams. Holding a Master of Business Administration (Health) from Flinders University, she earned Fellowship status with the Australasian College of Health Service Management in 2022. In 2023, Mirella was honoured as a scholarship recipient for the prestigious ‘Women in Leadership’ Program at the Monash Centre for Health Research and Implementation.
